BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 28125447)

  • 21. A long-term survivor with esophageal melanoma and pulmonary metastasis after single-stage esophagectomy and lobectomy: Case report and literature review.
    Zhao T; Kong FW; Wang H; Liu D; Wang CY; Luo JH; Zhang M; Wu WB
    Medicine (Baltimore); 2017 May; 96(21):e7003. PubMed ID: 28538413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
    Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
    Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
    Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
    BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor.
    Leslie C; Bowyer SE; White A; Grieu-Iacopetta F; Trevenen M; Iacopetta B; Amanuel B; Millward M
    Pathology; 2015 Oct; 47(6):557-63. PubMed ID: 26308130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The microenvironment in primary cutaneous melanoma with associated spontaneous tumor regression: evaluation for T-regulatory cells and the presence of an immunosuppressive microenvironment.
    Gray A; Grushchak S; Mudaliar K; Kliethermes S; Carey K; Hutchens KA
    Melanoma Res; 2017 Apr; 27(2):104-109. PubMed ID: 28125447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma.
    Maibach F; Sadozai H; Seyed Jafari SM; Hunger RE; Schenk M
    Front Immunol; 2020; 11():2105. PubMed ID: 33013886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T cells and skin tumors.
    Shindo M; Yoshida Y
    Recent Pat Inflamm Allergy Drug Discov; 2010 Nov; 4(3):249-54. PubMed ID: 20673223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
    Jacobs JF; Nierkens S; Figdor CG; de Vries IJ; Adema GJ
    Lancet Oncol; 2012 Jan; 13(1):e32-42. PubMed ID: 22225723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8
    Niederlova V; Tsyklauri O; Chadimova T; Stepanek O
    Eur J Immunol; 2021 Mar; 51(3):512-530. PubMed ID: 33501647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation.
    Cioplea M; Nichita L; Georgescu D; Sticlaru L; Cioroianu A; Nedelcu R; Turcu G; Rauta A; Mogodici C; Zurac S; Popp C
    J Immunol Res; 2020; 2020():5416843. PubMed ID: 33274240
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.